California DCC Eases Medical License Switch as Schedule III Takes Effect

The California Department of Cannabis Control announced on April 30 that it has streamlined the process for state-licensed cannabis operators to change a license designation between adult-use (A) and medicinal-use (M). Cultivation licensees no longer need to wait until license renewal to request a designation change, and DCC no longer requires a new local authorization for requests that switch a license to medical-only or add a medical designation to an existing adult-use license. The procedural change took effect immediately.

The shift in California’s regulatory implementation comes approximately one week after the U.S. Department of Justice issued a final order dated April 22 placing FDA-approved marijuana products and “marijuana subject to a state medical marijuana license” into Schedule III of the Controlled Substances Act. Cannabis that is neither in an FDA-approved product nor covered by a qualifying state medical license remains in Schedule I, and broader rescheduling is the subject of an expedited DEA administrative hearing scheduled to begin June 29, 2026.

What California’s Procedural Change Actually Does

DCC’s change applies to Form 27 (Notifications and Requests to Modify a License), the form California licensees use to switch or add a designation. Three procedural elements are altered.

First, cultivation licensees may submit a designation change at any point in the license term rather than waiting until annual renewal. Second, two specific request types — converting an existing license to M-designation only, or adding an M-designation to an existing A-designation license — no longer require new local authorization from the licensee’s city or county. Third, requests must be submitted by the designated responsible party using the email address on file with DCC, and the licensee must continue operating under the existing designation until the request is approved.

The underlying licensing architecture is unchanged. California’s adult-use program, established by Proposition 64 in November 2016 and codified in Bus. & Prof. Code §26000 et seq., continues to operate alongside the state’s earlier medical program, established by Proposition 215 in November 1996 and codified in Health & Safety Code §11362.5. Both frameworks remain in force; DCC’s change addresses only the procedural pathway between them.

The Federal Tax Implication Driving the Move

The change carries a specific commercial logic. Section 280E of the Internal Revenue Code disallows ordinary and necessary business expense deductions for entities trafficking in Schedule I or Schedule II controlled substances, with cost of goods sold the only available offset. Under the April 22 DOJ order, marijuana subject to a qualifying state medical license is now Schedule III for federal purposes, which means §280E ceases to apply to those operations beginning in tax year 2026. Adult-use marijuana operations remain Schedule I and remain subject to §280E.

Many California licensees hold both adult-use and medical designations. For those dually licensed operators, §280E exposure now turns on which portion of activity falls under which designation. A licensee with an adult-use-only license that wished to add a medical designation — and so move part of its activity into Schedule III tax treatment — previously had to wait until renewal and obtain new local authorization. Both procedural steps are now removed.

What the Change Does Not Do

DCC stated explicitly that its announcement “should not be considered advice regarding whether or how licensees should participate in the federal medicinal cannabis program,” and directed licensees with questions to legal counsel. State-level designation under California law is a separate question from federal DEA registration, which is required for state-licensed medical operators that wish to operate as Schedule III registrants. The DEA has opened a registration portal for state medical marijuana licensees; under the DOJ order, applications submitted within 60 days of publication of the rule in the Federal Register are eligible for expedited six-month processing, and applicants may continue operating under their state licenses during DEA review.

DCC also reported that it has requested a meeting with the DEA team implementing federal rescheduling, and that the DEA “has indicated it will share information publicly and all at once, rather than through state-specific briefings.” The U.S. Treasury Department and IRS have separately announced they intend to issue tax guidance for the marijuana industry in light of the Schedule III change, including for mixed operators whose activity spans both adult-use (Schedule I) and medical (Schedule III) designations. That guidance has not been published.

Current State of the Question

California’s procedural change addresses a single piece of state-level implementation: the pathway by which licensees adjust their designation under DCC. The federal-state interaction it sits within remains in flux. Schedule III status under federal law currently applies only to FDA-approved marijuana products and to marijuana under a qualifying state medical license; California’s adult-use activity, like all state-licensed adult-use activity, remains federally Schedule I. Whether the broader rescheduling proceeding initiated by the DOJ’s accompanying Notice of Proposed Rulemaking reaches a final rule depends on the June 29 DEA administrative hearing and the rulemaking process that follows. Until that proceeding concludes, California operators considering a designation change will be making the decision against an unsettled federal backdrop.